PremiumThe FlyCue Biopharma 25M share Spot Secondary priced at $0.79 Cue Biopharma announces common stock, warrant offering, no amount given Cue Biopharma receives $12M upfront in CUE-501 license pact PremiumThe FlyArtiva expands Board with appointment of Dan Baker, M.D Cue Biopharma’s Nasdaq Compliance Struggle: Risks and Implications for Future Stability Cue Biopharma Reports Increased Revenue Amid Ongoing Losses PremiumThe FlyBiotech Alert: Searches spiking for these stocks today Biotech Alert: Searches spiking for these stocks today Cue Biopharma announces pricing of $12M public offering 
